The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is launching an international call for projects under the umbrella of the JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION. The call, with financial support from the European Commission, includes 30 funding organisations from 21 JPIAMR member countries. The total estimated call budget is 24.9 million Euro.
The call “One Health interventions to prevent or reduce the development and transmission of AMR” has a two-step procedure
- 14 January 2021 (11.00 CET) – Call opens
- 16 March 2021 (12.00 CET) – Deadline pre-proposals
- 12 July 2021 – Deadline full proposals
Context of the call
With the current focus of the JPIAMR Strategic Research and Innovation Agenda, this call will specifically focus on tackling the rising threat of antibiotic resistance. Addressing the rising threat of antibiotic resistance requires a One Health approach since resistant bacteria, genetic elements and antibiotics are found in humans, animals and the environment. Declining clinical effectiveness of existing antibiotics together with the low and insufficient number of promising new antibiotics in the pipeline stresses the urgency to understand the mechanisms of emergence and transmission of antibiotic resistance. The European One Health Action Plan against AMR encourages the EU and its Member States to deliver innovative, effective and sustainable responses to AMR, especially to reduce the emergence and spread of AMR inside and outside the EU.
Through this call, the ERA-NET JPIAMR-ACTION intends to create and reinforce the collaboration between research partners coming from different countries and different fields of expertise to promote research on antibiotic resistance.
Topic of the call
Proposals should aim to either:
- Understand the impact of interventions on the development and transmission of antibiotic resistance in, and/or between, at least two One Health settings;
- Design, implement, evaluate, and/or compare innovative interventions to control the development and transmission of antibiotic resistance in, and/or between, at least two One Health settings.
As stated, research proposals must focus on at least two out of the three “One-Health” settings, being: Human Health, Animal Health, and Environment. Participation of low and middle income countries is encouraged.
Consortia should consists of a maximum of six (6) project partners (including non-funded partners). The maximum number of partners can be increased to seven (7) if the consortium includes a partner coming from either low- and middle-income countries, or from Hungary, Latvia, Lithuania and Poland. The budget of non-funded partners shall not exceed 30% of the total transnational project budget requested. Furthermore, consortia should always consist of a majority of project partners eligible for funding. Funding is granted for a maximum of three (3) years in accordance with national regulations and applicable legal provisions.
For more information about the research call and details about the application process, please visit the JPIAMR website.